Remove tag vitro-diagnostics
article thumbnail

Frost & Sullivan's Top 10 predictions for healthcare in 2021

Healthcare IT News - Telehealth

By unlocking the potential of multi-gene panels and NGS tests, the in-vitro diagnostic industry is accelerating efforts to transform cancer care by enabling precision oncology at all stages of the disease, regardless of specimen type. The global telehealth market will reach nearly $50 billion in 2021, and be embedded in virtual care.